conclusion : although the prevalence of methotrexate hepatotoxicity in this large cohort of patients with rheumatoid arthritis was low , a small but definite risk of hepatic fibrosis , not predictable by laboratory screening , still exists .
C0025677
methotrexate
C0003873
rheumatoid arthritis